Wall Street was largely effusive about Rocket Lab's execution and growth, as analysts reacted to the space company's second-quarter results from Tuesday.
Rocket Lab stock slid about 4% in early trading on Wednesday, after rising as much as 10% in premarket, from its previous close at $6.66 a share.
Here's what analysts had to say about Rocket Lab's performance.
Morgan Stanley — Overweight, $10 price target The firm's Kristine Liwag believes Rocket Lab stock "still has room to run" despite climbing about 70% so far this year.
Roth Capital – Buy, $10 price target Analyst Suji Desilva also emphasized Rocket Lab's "steady launch execution" and expansion toward becoming an "end-to-end vendor" in the space market.
Persons:
Ron Epstein, Epstein, Edison Yu, Morgan Stanley —, Kristine Liwag, Liwag, Stifel, Erik Rasmussen, Rasmussen, Roth, Suji Desilva, Jason Gursky, Gursky, Michael Bloom
Organizations:
Rocket, Bank of America, Deutsche, Citi
Locations:
premarket, U.S